ARCHIVES

Highlights of NCDDGs: 3 Drugs on Market, 12 in Development; Advisors Approve Plan to Issue $10.5 Million Contract For Pediatric Preclinical Testing Program

This article is from The Cancer Letter archive.

Vol. 28 No. 44 | November 29, 2002

Download PDF Visit The Full Archive

Related Articles

Radioactive Seeds Tested In Treatment Of NSCLC

September 26, 2008

ACCC To Consider Cancer Act Changes HSA Problems

January 7, 1977

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

CCRU, CCSP Projects Described; Plans Listed for DRCCA Applications Branch

November 11, 1983

Survivors With Gene Variant At More Risk For Heart Disease

June 25, 2010

Rauscher Explains Reasons for Treatment Switches

May 9, 1975